BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 1643607)

  • 1. Imaging lung cancer by scintigraphy with Indium 111-labeled F(ab')2 fragments of the anticarcinoembryonic antigen monoclonal antibody FO23C5.
    Buccheri G; Biggi A; Ferrigno D; D'Angeli B; Vassallo G; Leone A; Taviani M; Comino A
    Cancer; 1992 Aug; 70(4):749-59. PubMed ID: 1643607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-CEA immunoscintigraphy might be more useful than computed tomography in the preoperative thoracic evaluation of lung cancer. A comparison between planar immunoscintigraphy, single photon emission computed tomography (SPECT), and computed tomography.
    Buccheri G; Biggi A; Ferrigno D; Leone A; Taviani M; Quaranta M
    Chest; 1993 Sep; 104(3):734-42. PubMed ID: 8365283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-CEA immunoscintigraphy and computed tomographic scanning in the preoperative evaluation of mediastinal lymph nodes in lung cancer.
    Buccheri G; Biggi A; Ferrigno D; Quaranta M; Leone A; Vassallo G; Pugno F
    Thorax; 1996 Apr; 51(4):359-63. PubMed ID: 8733485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoscintigraphy using 111in-labelled F(ab')2 fragments of anti-carcinoembryonic antigen (CEA) monoclonal antibody for staging of non-small cell lung carcinoma.
    Vuillez JP; Moro D; Brambilla E; Brichon PY; Ferretti G; Saccavini JC; Brambilla C
    Eur J Cancer; 1994; 30A(8):1089-92. PubMed ID: 7654435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of primary lung cancer with indium 111 anti-carcinoembryonic antigen (type ZCE-025) monoclonal antibody scintigraphy.
    Krishnamurthy S; Morris JF; Antonovic R; Ahmed A; Galey WT; Duncan C; Krishnamurthy GT
    Cancer; 1990 Feb; 65(3):458-65. PubMed ID: 2297636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging with indium111-labeled anticarcinoembryonic antigen monoclonal antibody ZCE-025 of recurrent colorectal or carcinoembryonic antigen-producing cancer in patients with rising serum carcinoembryonic antigen levels and occult metastases.
    Patt YZ; Lamki LM; Shanken J; Jessup JM; Charnsangavej C; Ajani JA; Levin B; Merchant B; Halverson C; Murray JL
    J Clin Oncol; 1990 Jul; 8(7):1246-54. PubMed ID: 2193120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoscintigraphy using 111In-labeled F(ab')2 fragments of anticarcinoembryonic antigen monoclonal antibody for detecting recurrences of medullary thyroid carcinoma.
    Vuillez JP; Peltier P; Caravel JP; Chetanneau A; Saccavini JC; Chatal JF
    J Clin Endocrinol Metab; 1992 Jan; 74(1):157-63. PubMed ID: 1727816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioimmunoimaging of non-small cell lung cancer with 111In- and 99mTc-labeled monoclonal anti-CEA-antibodies.
    Kairemo KJ; Aronen HJ; Liewendahl K; Paavonen T; Heikkonen JJ; Virkkunen P; Mäki-Hokkonen H; Karonen SL; Brownell AL; Mäntylä MJ
    Acta Oncol; 1993; 32(7-8):771-8. PubMed ID: 8305225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic accuracy and tumor-targeting kinetics of complete versus fragmented 99mTc-labeled anti-carcinoembryonic antigen antibodies: an intraindividual comparison.
    Behr TM; Becker WS; Klein MW; Bair HJ; Scheele JR; Wolf FG
    Cancer Res; 1995 Dec; 55(23 Suppl):5786s-5793s. PubMed ID: 7493347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibody imaging in patients with colorectal cancer and increasing levels of serum carcinoembryonic antigen. Experience with ZCE-025 and IMMU-4 monoclonal antibodies and proposed directions for clinical trials.
    Patt YZ; Podoloff DA; Curley S; Smith R; Badkhamkar VA; Lamki LM; Jessup MM; Hohn DC
    Cancer; 1993 Jun; 71(12 Suppl):4293-7. PubMed ID: 8389662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two-step immunoscintigraphy for non-small-cell lung cancer staging using a bispecific anti-CEA/anti-indium-DTPA antibody and an indium-111-labeled DTPA dimer.
    Vuillez JP; Moro D; Brichon PY; Rouvier E; Brambilla E; Barbet J; Peltier P; Meyer P; Sarrazin R; Brambilla C
    J Nucl Med; 1997 Apr; 38(4):507-11. PubMed ID: 9098191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretargeted radioimmunoscintigraphy in patients with primary colorectal cancer using a bispecific anticarcinoembryonic antigen CEA X anti-di-diethylenetriaminepentaacetic acid F(ab')2 antibody.
    Aarts F; Boerman OC; Sharkey RM; Hendriks T; Chang CH; McBride WJ; Bleichrodt RP; Oyen WJ; Goldenberg DM
    Cancer; 2010 Feb; 116(4 Suppl):1111-7. PubMed ID: 20127959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of colorectal carcinoma by emission-computerized tomography after injection of 123I-labeled Fab or F(ab')2 fragments from monoclonal anti-carcinoembryonic antigen antibodies.
    Delaloye B; Bischof-Delaloye A; Buchegger F; von Fliedner V; Grob JP; Volant JC; Pettavel J; Mach JP
    J Clin Invest; 1986 Jan; 77(1):301-11. PubMed ID: 3484753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biokinetics of a F(ab')3 iodine-131 labeled antigen binding construct (Mab 35) directed against CEA in patients with colorectal carcinoma.
    Storto G; Buchegger F; Waibel R; Kuenzi G; Offord RE; Schubiger PA; Gillet M; Delaloye AB
    Cancer Biother Radiopharm; 2001 Oct; 16(5):371-9. PubMed ID: 11776754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoscintigraphy of adenocarcinomas by means of 111In-labelled F(ab')2 fragments of anti-CEA monoclonal antibody F023C5.
    Riva P; Paganelli G; Callegaro L; Bartoli MG; Turci D; Benini S; Deleide G; Scassellati GA; Viale G; Siccardi AG
    Nucl Med Commun; 1988 Aug; 9(8):577-89. PubMed ID: 3173916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-centre immunoscintigraphic study using indium-111-labelled CEA-specific and/or 19-9 monoclonal antibody F(ab')2 fragments.
    Chetanneau A; Baum RP; Lehur PA; Liehn JC; Perkins AC; Bares R; Bourguet P; Herry JY; Saccavini JC; Chatal JF
    Eur J Nucl Med; 1990; 17(5):223-9. PubMed ID: 2083556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Radioimmunodetection of colorectal cancer, using anti-CEA monoclonal antibody CEA 102: whole IgG versus F(ab')2 fragments].
    Wada K; Watanabe T; Tadokoro M; Sakamoto J; Murayama H; Sakuma S; Takagi H
    Nihon Geka Gakkai Zasshi; 1992 Mar; 93(3):266-73. PubMed ID: 1513308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoscintigraphy of small-cell lung cancer: a study using technetium and indium labelled anti-carcinoembryonic antigen monoclonal antibody preparations.
    Macmillan CH; Perkins AC; Wastie ML; Leach IH; Morgan DA
    Br J Cancer; 1993 Jun; 67(6):1391-4. PubMed ID: 8390288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of lymph node metastases in lung cancer: comparison of 131I-anti-CEA-anti-CA 19-9 immunoscintigraphy versus computed tomography.
    Boilleau G; Pujol JL; Ychou M; Faurous P; Marty-Ané C; Michel FB; Godard P
    Lung Cancer; 1994 Sep; 11(3-4):209-19. PubMed ID: 7812699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of the FO23C5 anti-CEA antibody fragment labelled with 99Tcm and 111In: a comparison in patients.
    Hnatowich DJ; Mardirossian G; Rusckowski M; Roy S; Bushe H; Griffin TW; Brill AB
    Nucl Med Commun; 1993 Jan; 14(1):52-63. PubMed ID: 8423936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.